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Interestingly, we can use the backscattering effect to 
enhance the dose homogeneity in the target volume and a 
theoretical shield design will be presented.  
 
 
Figure 1: PDD & Profile measured curves and MC simulation  
 
 
Figure 2: Dose map for a Mobetron 12 MeV Beam, 5.5 cm 
Applicator and (Al/Pb) shield plate in water phantom 
 
Conclusions:  
- All of the studied shielding plates are clinically acceptable. 
Normally, the surgeon would prefer the thinnest shield 
(Al/Pb). 
- The good alignment of the applicator and the shield is a key 
issue  
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Purpose/Objective: Recent studies have warned about late 
toxicity, primarily cardiac toxicity, in patients diagnosed with 
breast cancer who have received radiation therapy. 
Although there are numerous publications and protocols 
there is no uniform recommendations for 3D radiation 
therapy for breast cancer about which are the best 
dose/volume constraints to evaluate this treatment. 
The purpose of this study is to quantify and compare 
different dose/volume constraints for the organs at risk 
(OARs) in breast cancer treatment based in the DVH of each 
study, in order to establish the most useful parameters to 
evaluate this type of treatment in our institution. 
Materials and Methods: 544 women were evaluated. Studies 
were grouped regarding the type of treatment (breast/chest 
wall, breast + boost, breast + regional nodal irradiation (RNI), 
breast+boost+RNI) and the fractionation scheme (2Gy or 
2.66Gy per fraction). 
Different dose/volume constraints for the heart and lung 
have been evaluated for each patient (Table 1). 
Also, for each patient the clinical pathology before and after 
the treatment has been evaluated. 
 
 
Results: From 544 patients only 2 developed symptomatic 
pulmonary complications and 4 patients developed cardiac 
complications probably related with the radiotherapy 
treatment.  
Regarding the dose/volume constraints: 
•For both lungs, V20Gy(16Gy*) <25% is achieved in about 97% 
of the patients. 
•For the ipsilateral lung, Dmean<17 Gy is achieved in more 
than 95% of the patients, except in treatments which 
includes the RNI, where only 64% meet the criteria. 
Furthermore, the criteria V30Gy<200cc is only achieved by 
33% of the patients, in the best situation (breast/chest wall 
hypofractionated) meanwhile for treatments which includes 
RNI only 9% meet the objective. For V20Gy<25% the results 
are in same direction as V30Gy<200cc. 
•For the heart, V30Gy(24Gy*)<30 cc is achieved by 29% of the 
patients in the best situation. V20Gy<10%, V40Gy<5% and 
V25Gy<10% is achieved by 45%, 41.4% and 52% in the best 
situations, meanwhile V45Gy<50% and V60Gy<30% is achieved 
by 100%.  
(*) value for hypofractionated treatments 
Conclusions: The type of treatment have a big influence in 
the percentage of cases that meet the dose/volume 
constraints. Treatments which include the RNI have a low 
percentage of achievements. 
According to our data, we can conclude that the 
V30(24)Gy<30cc for the heart and the V30(24)Gy<200cc for 
the ipsilateral lung are quite ambitious constraints and 
presents a strong dependency of the appearance of the RNI. 
Also, parameters as the V45Gy<33% , for the ipsilateral lung 
and V45Gy<50% for the heart, are very relaxed and the 
achievement of these constraints doesn’t mean that the plan 
would be an optimal plan. 
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Finnaly, we strongly recommend to develop a different set of 
dose/volume constraints for cases that include the RNI. 
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Purpose/Objective: To investigate a Hybrid IMRT/VMAT 
technique which combines intensity modulated radiation 
therapy (IMRT) and volumetric modulated arc therapy (VMAT) 
for the treatment of non-small cell lung cancer (NSCLC).  
Materials and Methods: 2 partial arcs VMAT, 5-field IMRT and 
Hybrid IMRT/VMAT plans were created for 15 patients with 
NSCLC. The Hybrid IMRT/VMAT plans were combination of 2 
partial arcs VMAT and 5-field IMRT. The dose distribution of 
planning target volume (PTV) and organs at risk (OARs) for 
Hybrid IMRT/VMAT was compared with IMRT and VMAT. The 
monitor units (MUs) and treatment delivery time were also 
evaluated.  
Results: Hybrid IMRT/VMAT significantly improved the target 
conformity and homogeneity compared with IMRT and VMAT. 
The V30 of normal lung for hybrid plans was significantly 
lower than IMRT plans (17.7% vs 18.7%; p<0.05) and VMAT 
plans (17.7% vs 18.4%; p<0.05). The V5, V10, V30 and mean lung 
dose (MLD) of normal lung for hybrid plans were 5.1% ,7.7%, 
3.8% and 3.9% lower than those for VMAT plans, respectively 
(p<0.05). The maximum dose of spinal cord for hybrid plans 
was 5.6 Gy lower than that for IMRT plans (p<0.05). The dose 
received by esophagus and heart for hybrid plans were 
significantly lower than those for IMRT plans. The mean 
delivery time of IMRT, VMAT and hybrid plans were 280 s, 114 
s, and 327 s, respectively. The mean MUs needed for IMRT, 
VMAT and hybrid plans were 933, 512, and 737, respectively.  
Conclusions: The Hybrid IMRT/VMAT technique significantly 
improved the target conformity and homogeneity compared 
with IMRT and VMAT. It reduced V5, V10, V30 and MLD of 
normal lung compared with VMAT, and protected the OARs 
better with fewer MUs compared with IMRT. Hybrid 
IMRT/VMAT technique can be a viable radiotherapy technique 
with better plan quality. 
   
EP-1568   
Increased patient comfort for generating moulds using a 3D 
printer 
M. Luesink1, R. Veenstra1, A. Loopstra1, R. Gorter1, K.L. 
Pasma1 
1ARTI - Arnhems RadioTherapy Institute, Physics Department, 
Arnhem, The Netherlands  
 
Purpose/Objective: To compensate for the irregular surface 
of a patient head custom bolus is often used to get an 
acceptable dose distribution. This bolus is created on top of a 
model of the patient’s head. The current method is to create 
a mold with plaster cast. This mold is then filled with liquid 
plaster to create a model of the patient’s face. This 
procedure is, in terms of required time and comfort, not 
patient friendly. With the novel imaging method presented 
here, a digital model of the patient’s face is created with a 
real-time 3D Kinect camera within a minute without touching 
the patient. This 3D model is printed with a 3D printer. On 
top of this printed mold the bolus can be constructed as 
usual. This 3D scanning method is compared with the 
traditional procedure. 
Materials and Methods: The 3D digital model is acquired with 
a Microsoft Kinect camera (Xbox 360 Kinect Sensor) 
connected to a high end PC (Intel i7-4770 3.4 GHz, 16GB 
RAM, Radeon R9 200). The acquisition software (Kinect Fusion 
Explorer) provides 3D object scanning. The resulting 
reconstructed 3D model of the patients head is cropped and 
further prepared with in-house developed software. Finally it 
is printed using Polylactide (PLA) in a 1:1 scale, with a 3D 
printer (Orange-A420 dual extruder, 3D printservice Arnhem, 
NL).  
To evaluate the procedure we created models using the 
traditional method and the 3D printer method of the same 
patient. On top of both models a bolus is constructed. Two 
CT scans are acquired for this patient using the two created 
boluses. 
Results: 
 
 
Within a minute a digital 3D model is created of the patients 
head. Directly after the imaging procedure the patient can 
leave. The figure shows the 3D printed face model on the 
right. Printing takes about 5 hours depending on the size of 
the model, layer thickness and infill percentage. This is done 
at night, no Radiotherapy Technician (RTT) has to be present. 
The traditional mold on the left was generated in 2 hours in 
total. 
The bolus constructed on the 3D printed model fits better to 
the patient then the traditional method. Smaller air caps 
were observed. Without any physical contact the patient is 
more relaxed. No construction material is used that can 
deform the shape of the patients face. Printing the model 
